BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Giampaolo B, Giuseppe P, Michele B, Alessandro M, Fabrizio S, Alfonso C. Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study. World J Gastroenterol 2006; 12(14): 2201-2204 [PMID: 16610021 DOI: 10.3748/wjg.v12.i14.2201]
URL: https://www.wjgnet.com/1007-9327/full/v12/i14/2201.htm
Number Citing Articles
1
Fridrik Thor Sigurbjörnsson, Ingvar Bjarnason. Leukocytapheresis for the treatment of IBDNature Clinical Practice Gastroenterology & Hepatology 2008; 5(9): 509 doi: 10.1038/ncpgasthep1209
2
G. Bresci, G. Parisi, A. Mazzoni, F. Scatena, A. Capria. Treatment of patients with acute ulcerative colitis: Conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): A pilot studyDigestive and Liver Disease 2007; 39(5): 430 doi: 10.1016/j.dld.2007.01.001
3
Munenori Itagaki, Masayuki Saruta, Toshio Iinuma, Seiji Arihiro, Tomohiro Kato, Hisao Tajiri. Infliximab- and Immunosuppressant-Resistant Crohn’s Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with PrednisoloneCase Reports in Gastroenterology 2012; 6(1): 118 doi: 10.1159/000334428
4
Naoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, Hiroki Takahashi, Ryuichi Iwakiri, Takayuki Yamamoto, Tomoo Nakagawa, Takumi Fukuchi, Satoshi Motoya, Reiko Kunisaki, Shingo Kato, Fumihito Hirai, Yoh Ishiguro, Satoshi Tanida, Sakiko Hiraoka, Keiichi Mitsuyama, Shunji Ishihara, Shinji Tanaka, Michiro Otaka, Taro Osada, Takashi Kagaya, Yasuo Suzuki, Hiroshi Nakase, Hiroyuki Hanai, Kenji Watanabe, Nobuhito Kashiwagi, Toshifumi Hibi. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s diseaseBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0390-3
5
Joaquin Sanchez-Garcia, Juana Serrano-López, Valle García-Sanchez, Miguel A Alvarez-Rivas, Rosario Jimenez-Moreno, Carlos Pérez-Seoane, Concepcion Herrera-Arroyo, Josefina Serrano, Juan F De Dios, Antonio Torres-Gomez. Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patientsJournal of Gastroenterology and Hepatology 2010; 25(12): 1869 doi: 10.1111/j.1440-1746.2010.06377.x
6
R. Caprilli, V. D’Ovidio. Leukocytapheresis as promising therapy for inflammatory bowel diseaseDigestive and Liver Disease 2007; 39(5): 435 doi: 10.1016/j.dld.2007.02.003
7
Atsushi Noguchi, Kenji Watanabe, Shosaku Narumi, Hirokazu Yamagami, Yasuhiro Fujiwara, Kazuhide Higuchi, Nobuhide Oshitani, Tetsuo Arakawa. The production of interferon-γ-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activityJournal of Gastroenterology 2007; 42(12): 947 doi: 10.1007/s00535-007-2118-9
8
Giampaolo Bresci. Granulocytapheresis in the treatment of patients with active ulcerative colitisExpert Review of Gastroenterology & Hepatology 2008; 2(5): 639 doi: 10.1586/17474124.2.5.639
9
Bruce E Sands, Seymour Katz, Douglas C Wolf, Brian G Feagan, Tao Wang, Lisa-Marie Gustofson, Cindy Wong, Margaret K Vandervoort, Stephen Hanauer. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's diseaseGut 2013; 62(9): 1288 doi: 10.1136/gutjnl-2011-300995
10
Shin-ichiro Takeda, Toru Sato, Tatsuro Katsuno, Tomoo Nakagawa, Yoshiko Noguchi, Osamu Yokosuka, Yasushi Saito. Adsorptive Depletion of α4 Integrinhi- and CX3CR1hi-Expressing Proinflammatory Monocytes in Patients with Ulcerative ColitisDigestive Diseases and Sciences 2010; 55(7): 1886 doi: 10.1007/s10620-009-0974-2
11
Kotaro Kuwaki, Keiichi Mitsuyama, Hayato Kaida, Hidetoshi Takedatsu, Shinichiro Yoshioka, Hiroshi Yamasaki, Ryosuke Yamauchi, Shuhei Fukunaga, Toshi Abe, Osamu Tsuruta, Takuji Torimura. A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapyCytotherapy 2016; 18(2): 291 doi: 10.1016/j.jcyt.2015.10.010
12
Masahiro Iizuka, Takeshi Etou, Yosuke Shimodaira, Takashi Hatakeyama, Shiho Sagara. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitisWorld Journal of Gastroenterology 2021; 27(12): 1194-1212 doi: 10.3748/wjg.v27.i12.1194
13
Rodolfo Sacco, Antonio Romano, Alessandro Mazzoni, Marco Bertini, Graziana Federici, Salvatore Metrangolo, Giuseppe Parisi, Cecilia Nencini, Celeste Giampietro, Michele Bertoni, Emanuele Tumino, Fabrizio Scatena, Giampaolo Bresci. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: A prospective observational studyJournal of Crohn's and Colitis 2013; 7(12): e692 doi: 10.1016/j.crohns.2013.06.012
14
Reikei Matsuda, Tomoko Koide, Chikako Tokoro, Tsuyoshi Yamamoto, Tenʼi Godai, Taiki Morohashi, Yuji Fujita, Daisuke Takahashi, Ichiro Kawana, Shinichiro Suzuki, Satoshi Umemura. Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent DiseaseInflammatory Bowel Diseases 2009; 15(3): 328 doi: 10.1002/ibd.20759
15
Yasushi Umehara, Masatoshi Kudo, Masanori Kawasaki. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitisWorld Journal of Gastroenterology 2008; 14(34): 5316-5321 doi: 10.3748/wjg.14.5316
16
Tomotaka Tanaka, Takayuki Yamamoto, Koji Sawada, Rodolfo Sacco. Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Expert Review of Gastroenterology & Hepatology 2017; 11(8): 749 doi: 10.1080/17474124.2017.1341309
17
Pilar Nos, Eugeni Domènech. Tratamiento con aféresis en la enfermedad inflamatoria intestinalGastroenterología y Hepatología 2009; 32(7): 509 doi: 10.1016/j.gastrohep.2009.01.183
18
Giampaolo Bresci, Giuseppe Parisi, Alessandro Mazzoni, Fabrizio Scatena, Alfonso Capria. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow upJournal of Gastroenterology and Hepatology 2008; 23(11): 1678 doi: 10.1111/j.1440-1746.2008.05595.x
19
Takafumi Ando, Osamu Watanabe, Kazuhiro Ishiguro, Osamu Maeda, Daisuke Ishikawa, Masaaki Minami, Motofusa Hasegawa, Shinya Kondo, Yasuyuki Goto, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto. Relationships betweenHelicobacter pyloriinfection status, endoscopic, histopathological findings, and cytokine production in the duodenum of Crohn's disease patientsJournal of Gastroenterology and Hepatology 2008; 23: S193 doi: 10.1111/j.1440-1746.2008.05438.x
20
Yoon Hee Kim, Hyuck-Se Kwon, Dae Hwan Kim, Eun Kyung Shin, Young-Hee Kang, Jung Han Yoon Park, Hyun-Kyung Shin, Jin-Kyung Kim. 3,3′-diindolylmethane attenuates colonic inflammation and tumorigenesis in miceInflammatory Bowel Diseases 2009; 15(8): 1164 doi: 10.1002/ibd.20917
21
David Schwartz, John R. Ferguson. Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresisCurrent Medical Research and Opinion 2007; 23(11): 2715 doi: 10.1185/030079907X233241